Conference
Prodige: A phase 3 randomized placebo-controlled trial of thromboprophylaxis using dalteparin low-molecular-weight heparin (LMWH) in patients with newly diagnosed malignant glioma
Authors
Perry J; Rogers L; Laperriere N; Julian J; Geerts W; Agnelli G; Malkin M; Sawaya R; Baker R; Finch T
Volume
7
Pagination
pp. 322-322
Publisher
DUKE UNIV PRESS
Publication Date
July 1, 2005
Name of conference
2nd Quadrennial Meeting of the World-Federation-of-Neuro-Oncology/6th Meeting of the European-Association-for-Neur-Oncology
Conference place
Edinburgh, SCOTLAND
Conference start date
May 5, 2005
Conference end date
May 8, 2005
Conference proceedings
NEURO-ONCOLOGY
Issue
3
ISSN
1522-8517